HighVista Strategies’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.5M | Sell |
68,048
-5,704
| -8% | -$210K | 0.92% | 27 |
|
|
2025
Q1 | $2.61M | Buy |
73,752
+16,506
| +29% | +$584K | 1% | 18 |
|
|
2024
Q4 | $2.5M | Buy |
57,246
+1,684
| +3% | +$73.7K | 0.93% | 28 |
|
|
2024
Q3 | $2.52M | Buy |
55,562
+15,479
| +39% | +$702K | 0.87% | 34 |
|
|
2024
Q2 | $1.56M | Buy |
40,083
+25,758
| +180% | +$1,000K | 0.57% | 64 |
|
|
2024
Q1 | $462K | Sell |
14,325
-8,325
| -37% | -$268K | 0.16% | 122 |
|
|
2023
Q4 | $650K | Buy |
22,650
+4,645
| +26% | +$133K | 0.24% | 108 |
|
|
2023
Q3 | $498K | Buy |
+18,005
| New | +$498K | 0.23% | 108 |
|
|
2022
Q4 | – | Sell |
-42,056
| Closed | -$829K | – | 124 |
|
|
2022
Q3 | $829K | Buy |
42,056
+21,371
| +103% | +$421K | 0.47% | 52 |
|
|
2022
Q2 | $403K | Buy |
+20,685
| New | +$403K | 0.24% | 81 |
|
|
2021
Q4 | – | Sell |
-23,637
| Closed | -$650K | – | 108 |
|
|
2021
Q3 | $650K | Sell |
23,637
-1,401
| -6% | -$38.5K | 0.43% | 66 |
|
|
2021
Q2 | $795K | Buy |
25,038
+8,046
| +47% | +$255K | 0.56% | 52 |
|
|
2021
Q1 | $780K | Buy |
+16,992
| New | +$780K | 0.58% | 30 |
|